NOT KNOWN FACTS ABOUT CABOZANTINIB

The greatest obstacle during the scientific application of pan-CDK inhibitors is their minimal specificity and considerable Negative effects on ordinary somatic cells. So as to fix this problem, researchers have effectively produced a number of certain CDK inhibitors, including CDK4/six-, CDK7-, CDK9-, CDK12/13-inhibitors etc. Each variety of tumor